Brief: Sienna Biopharmaceuticals posts qtrly loss per share $1.12

Sienna Biopharmaceuticals

09/11/2017 13:05

Nov 9 (Reuters) - Sienna Biopharmaceuticals Inc  SNNA.O  
    * Sienna Biopharmaceuticals reports third quarter 2017 
financial 
results 
    * Sienna Biopharmaceuticals Inc - Qtrly loss per share 
$1.12 
    * Sienna Biopharmaceuticals Inc - Sienna's cash and cash 
equivalents as of Sept. 30, 2017, totaled approximately $88.6 
million 
    * Sienna Biopharmaceuticals -  Expects non-cash component 
related 
to acquisition of creabilis to continue to impact G&A expenses 
in future quarters 
 
Source text for Eikon:  ID:nGNXOGTWFa  
Further company coverage:  SNNA.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))